Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models

Immunity

Volumn 15, Issue 3, 2001, Pages 387-395

  Todd, John A ^a   Wicker, Linda S ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; PREPROINSULIN;

ALLELE; ANTIGEN RECOGNITION; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MODEL; GENE CLUSTER; GENE FUNCTION; GENE LOCUS; GENE MAPPING; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATORY DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTECTION; REVIEW;

EID: 0034812119     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00202-3     Document Type: Review

References (75)

1. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population
2. Insulin-dependent diabetes mellitus as an autoimmune disease
3. Human type 1 diabetes and the insulin gene: Principles of mapping polygenes
4. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
5. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation
6. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjogren's syndrome-like autoimmune exocrinopathy
7. Protection against diabetes and improved NK/NKT cell performance in NOD.NK1.1 mice congenic at the NK complex
8. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus
9. Statistical modeling of interlocus interactions in a complex disease. Rejection of the multiplicative model of epistasis in type 1 diabetes
10. A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients
11. A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins
12. The BB rat as a model for autoimmune thyroiditis: Relevance for the pathogenesis of human disease
13. Evidence of a non-MHC susceptibility locus in type 1 diabetes linked to HLA on chromosome 6
14. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen
15. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing II2
16. Genetic analysis of chromosome 2 in type 1 diabetes: Analysis of putative loci IDDM7, IDDM12, and IDDM13 and candidate genes NRAMP1 and IA-2 and the interleukin-1 gene cluster. IMDIAB Group
17. Finding the molecular basis of quantitative traits: Successes and pitfalls
18. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice
19. Diabetes and gender
20. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: Time trend analysis
21. Peripheral-antigen-expressing cells in thymic medulla: Factors in self-tolerance and autoimmunity
22. Risk assessment, prediction and prevention of type 1 diabetes
23. Cutting edge: Homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice
24. The NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans
25. Both CD4(+) T cells and CD8(+) T cells are required for iodine accelerated thyroiditis in NOD mice
26. The NOD mouse and its related strains
27. Identification of a new susceptibility locus for insulin-dependent diabetes mellitus by ancestral haplotype congenic mapping
28. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes
29. + regulatory T cells induced by an agonist self-peptide
30. Autoreactivity of T cells from nonobese diabetic mice: An I-Ag7-dependent reaction
31. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
32. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease
33. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes
34. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities
35. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5 and IDDM8
36. Localising quantitative trait loci in the NOD mouse model of type 1 diabetes
37. Congenic mapping of the type 1 diabetes locus to a 780 kb region of mouse chromosome 3: Identification of a candidate segment of ancestral DNA by haplotype mapping
38. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137
39. A search for type 1 diabetes susceptibility genes in families from the United Kingdom
40. Suggestive evidence for association of human chromosome 18q12-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases
41. The BB/Wor rat and the balance hypothesis of autoimmunity
42. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes
43. Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13
44. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry
45. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
46. Pancreatic β cells in insulin-dependent diabetes
47. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1
48. Localization of two insulin-dependent diabetes (Idd) genes to the Idd10 region on mouse chromosome 3
49. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene?
50. The insulin gene is transcribed in the human thymus and transcriptional levels correlate with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes
51. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs
52. Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice
53. Heterogeneity in type I diabetes: Analysis of monozygotic twins in Great Britain and the United States
54. Searching for genetic determinants in the new millennium
55. A novel NOD-derived murine model of primary Sjogren's syndrome
56. Type 1a diabetes induced by infection and immunization
57. The role of iodine in autoimmune thyroiditis
58. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity
59. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice
60. Subcongenic analysis of the Idd13 locus in NOD/Lt mice: Evidence for several susceptibility genes including a possible diabetogenic role for β 2-microglobulin
61. Experimental annotation of the human genome using microarray technology
62. Molecular basis of celiac disease
63. Insulin-dependent diabetes mellitus
64. A protective role of the environment in the development of type 1 diabetes?
65. From genomics to aetiology in a multifactorial disease, type 1 diabetes
66. Genetic analysis of autoimmune type 1 diabetes mellitus in mice
67. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production
68. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus
69. Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family
70. Genetic analysis of autoimmune disease
71. Major histocompatibility complex-linked control of autoimmunity
72. Genetic control of autoimmune diabetes in the NOD mouse
73. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population
74. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes
75. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB study